222 related articles for article (PubMed ID: 30130687)
1. Challenges and perspectives in the treatment of diabetes associated breast cancer.
Samuel SM; Varghese E; Varghese S; Büsselberg D
Cancer Treat Rev; 2018 Nov; 70():98-111. PubMed ID: 30130687
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
3. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers.
Varghese E; Samuel SM; Abotaleb M; Cheema S; Mamtani R; Büsselberg D
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30248941
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
[TBL] [Abstract][Full Text] [Related]
5. Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.
Damjanović A; Matić IZ; Ðorđić M; Ðurović MN; Nikolić S; Roki K; Milovanović Z; Antić-Stanković J; Džodić R; Damjanović S; Kanjer K; Abu Rabi Z; Juranić Z
Pathol Oncol Res; 2015 Jul; 21(3):605-12. PubMed ID: 25351941
[TBL] [Abstract][Full Text] [Related]
6. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
7. [Metformin, an antidiabetic molecule with anti-cancer properties].
Beck E; Scheen AJ
Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and Cancer: a Review of Current Knowledge.
Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686
[TBL] [Abstract][Full Text] [Related]
9. [New perspectives for metformin in cancer therapy].
Loubière C; Dirat B; Tanti JF; Bost F
Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.
Shlomai G; Neel B; LeRoith D; Gallagher EJ
J Clin Oncol; 2016 Dec; 34(35):4261-4269. PubMed ID: 27903154
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and diabetes mellitus.
Schott S; Schneeweiss A; Sohn C
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):673-7. PubMed ID: 20533174
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
Suh S; Kim KW
Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
[TBL] [Abstract][Full Text] [Related]
13. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
16. The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
Bar D; Lavie O; Stein N; Feferkorn I; Shai A
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():227-231. PubMed ID: 27890326
[TBL] [Abstract][Full Text] [Related]
17. A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer.
Jaiswal P; Tripathi V; Nayak A; Kataria S; Lukashevich V; Das AK; Parmar HS
Curr Cancer Drug Targets; 2021; 21(10):829-848. PubMed ID: 34468298
[TBL] [Abstract][Full Text] [Related]
18. Expanding the therapeutic spectrum of metformin: from diabetes to cancer.
Coperchini F; Leporati P; Rotondi M; Chiovato L
J Endocrinol Invest; 2015 Oct; 38(10):1047-55. PubMed ID: 26233338
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
20. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer.
Samuel SM; Varghese E; Kubatka P; Triggle CR; Büsselberg D
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
